OSI Systems Inc/ US6710441055 /
2024-03-28 9:00:00 PM | Chg. +1.3800 | Volume | Bid10:04:33 PM | Ask10:04:33 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
142.8200USD | +0.98% | 100,939 Turnover: 9.09 mill. |
135.4200Bid Size: 100 | 142.7000Ask Size: 500 | 2.43 bill.USD | - | 26.21 |
GlobeNewswire
03-19
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie
GlobeNewswire
03-18
BIVI 4-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investo...
GlobeNewswire
03-17
BIOVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has...
GlobeNewswire
03-15
BIVI 4-DAY DEADLINE ALERT: Hagens Berman Encourages BioVie (BIVI) Investors with Substantial Losses ...
GlobeNewswire
03-14
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioV...
GlobeNewswire
03-14
TUESDAY DEADLINE: Berger Montague Advises BioVie Inc. (NASDAQ: BIVI) Investors to Inquire About a Se...
GlobeNewswire
03-14
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mob...
GlobeNewswire
03-12
BioVie (BIVI) Faces Securities Fraud Class Action After Uncovering Potential Scientific Misconduct I...
GlobeNewswire
03-10
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mob...
GlobeNewswire
03-07
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioV...
GlobeNewswire
03-06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
03-02
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
03-01
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bi...
GlobeNewswire
02-27
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
02-23
Investors Sue BioVie (BIVI) After Potential Scientific Misconduct In Failed Phase 3 Clinical Trial U...
GlobeNewswire
02-23
BIOVIE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encoura...
GlobeNewswire
02-23
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
02-20
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against BioVie Inc. - B...
GlobeNewswire
02-19
Investors Sue BioVie (BIVI) After Potential Scientific Misconduct In Failed Phase 3 Clinical Trial U...
GlobeNewswire
02-19
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
02-16
BioVie (BIVI) Faces Securities Fraud Class Action After Uncovering Potential Scientific Misconduct I...
GlobeNewswire
02-15
BIOVIE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh...